Preferred Bank (NASDAQ:PFBC) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.57 by 5.45 percent. This is a 50.56 percent increase over earnings of $1.80 per share from the same period last year.
Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target
Needham analyst Joseph Stringer reiterates Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $23 price target.
